NovoCure. has filed a patent for methods and compositions to prevent or disrupt mitosis of pluripotent stem cells, treat ectopic pregnancy, and reduce viability. Claims 1-37 have been canceled. GlobalData’s report on NovoCure gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights NovoCure Ltd - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on NovoCure, Neuromodulation implants was a key innovation area identified from patents. NovoCure's grant share as of January 2024 was 28%. Grant share is based on the ratio of number of grants to total number of patents.

Preventing mitosis of pluripotent stem cells

Source: United States Patent and Trademark Office (USPTO). Credit: NovoCure Ltd

A recently filed patent (Publication Number: US20240024669A1) outlines a method for treating ectopic pregnancy using an alternating electric field. The method involves distributing the electric field to a specific target site in the subject, with the frequency ranging from 25 kHz to 1 MHz and a field strength of 0.1 V to 10 V/cm. The target site can include ectopic pregnancy or pluripotent stem cells, such as fetal, embryonic, or induced pluripotent stem cells. Additionally, the method may involve administering certain medications to the subject, who could be pregnant and exhibit elevated levels of human chorionic gonadotropin (HCG) or an abnormal pattern in the rise of HCG levels. Diagnosis of ectopic pregnancy can be confirmed via ultrasound.

Furthermore, the method described in the patent involves the use of an alternating electric field to prevent or disrupt mitosis of pluripotent stem cells at the target site, without relying on heat to kill or ablate the cells. The application of the electric field can be facilitated by arrays of electrodes present on the subject's skin. The patent also mentions the use of gefitinib, methotrexate, or a combination thereof in conjunction with the electric field treatment. Overall, the method offers a novel approach to treating ectopic pregnancy and related conditions by leveraging the unique properties of alternating electric fields to target specific sites within the body, potentially opening up new avenues for medical intervention in reproductive health.

To know more about GlobalData’s detailed insights on NovoCure, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies